Literature DB >> 23380987

Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite.

Lyudmila Spevak1, Carol R Flach, Tracey Hunter, Richard Mendelsohn, Adele Boskey.   

Abstract

Acid phosphate substitution into mineralized tissues is an important determinant of their mechanical properties and their response to treatment. This study identifies and validates Fourier transform infrared spectroscopic imaging (FTIRI) spectral parameters that provide information on the acid phosphate (HPO4) substitution into hydroxyapatite in developing mineralized tissues. Curve fitting and Fourier self-deconvolution were used to identify subband positions in model compounds (with and without HPO4). The intensity of subbands at 1127 and 1110 cm(-1) correlated with the acid phosphate content in these models. Peak height ratios of these subbands to the ν3 vibration at 1096 cm(-1) found in stoichiometric apatite were evaluated in the model compounds and mixtures thereof. FTIRI spectra of bones and teeth at different developmental ages were analyzed using these spectral parameters. Factor analysis (a chemometric technique) was also conducted on the tissue samples and resulted in factor loadings with spectral features corresponding to the HPO4 vibrations described above. Images of both factor correlation coefficients and the peak height ratios 1127/1096 and 1112/1096 cm(-1) demonstrated higher acid phosphate content in younger vs. more mature regions in the same specimen. Maps of the distribution of acid phosphate content will be useful for characterizing the extent of new bone formation, the areas of potential decreased strength, and the effects of therapies such as those used in metabolic bone diseases (osteoporosis, chronic kidney disease) on mineral composition. Because of the wider range of values obtained with the 1127/1096 cm(-1) parameter compared to the 1110/1096 cm(-1) parameter and the smaller scatter in the slope, it is suggested that this ratio should be the parameter of choice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380987      PMCID: PMC3631290          DOI: 10.1007/s00223-013-9695-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  38 in total

1.  Spatial variation in osteonal bone properties relative to tissue and animal age.

Authors:  Samuel Gourion-Arsiquaud; Jayme C Burket; Lorena M Havill; Edward DiCarlo; Stephen B Doty; Richard Mendelsohn; Marjolein C H van der Meulen; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

Review 2.  Disease recognition by infrared and Raman spectroscopy.

Authors:  Christoph Krafft; Gerald Steiner; Claudia Beleites; Reiner Salzer
Journal:  J Biophotonics       Date:  2009-02       Impact factor: 3.207

3.  Characterization of archaeological burnt bones: contribution of a new analytical protocol based on derivative FTIR spectroscopy and curve fitting of the nu1nu3 PO4 domain.

Authors:  M Lebon; I Reiche; F Fröhlich; J-J Bahain; C Falguères
Journal:  Anal Bioanal Chem       Date:  2008-10-31       Impact factor: 4.142

4.  Effect of HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth.

Authors:  Laura G Sloofman; Kostas Verdelis; Lyudmila Spevak; Majd Zayzafoon; Mistuo Yamauchi; Lynn M Opdenaker; Mary C Farach-Carson; Adele L Boskey; Catherine B Kirn-Safran
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

5.  Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.

Authors:  Chiachien J Wang; I-Ping Chen; Boguslawa Koczon-Jaremko; Adele L Boskey; Yasuyoshi Ueki; Liisa Kuhn; Ernst J Reichenberger
Journal:  Bone       Date:  2010-02-01       Impact factor: 4.398

6.  Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy.

Authors:  Hanna Isaksson; Mikael J Turunen; Lassi Rieppo; Simo Saarakkala; Inari S Tamminen; Jarno Rieppo; Heikki Kröger; Jukka S Jurvelin
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

7.  Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.

Authors:  Adele L Boskey; Bruce D Gelb; Eric Pourmand; Valery Kudrashov; Stephen B Doty; Lyudmila Spevak; Mitchell B Schaffler
Journal:  Calcif Tissue Int       Date:  2009-01-27       Impact factor: 4.333

8.  Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition.

Authors:  Hayden-William Courtland; Philip Nasser; Andrew B Goldstone; Lyudmila Spevak; Adele L Boskey; Karl J Jepsen
Journal:  Calcif Tissue Int       Date:  2008-10-15       Impact factor: 4.333

9.  Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture.

Authors:  Samuel Gourion-Arsiquaud; Dan Faibish; Elizabeth Myers; Lyudmila Spevak; Juliet Compston; Anthony Hodsman; Elizabeth Shane; Robert R Recker; Elizabeth R Boskey; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2009-09       Impact factor: 6.741

10.  The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice.

Authors:  Adele Boskey; Aaron Frank; Yukiji Fujimoto; Lyudmila Spevak; Kostas Verdelis; Bruce Ellis; Nancy Troiano; William Philbrick; Thomas Carpenter
Journal:  Calcif Tissue Int       Date:  2008-12-12       Impact factor: 4.333

View more
  29 in total

1.  Studying variations in bone composition at nano-scale resolution: a preliminary report.

Authors:  Samuel Gourion-Arsiquaud; Curtis Marcott; Qichi Hu; Adele L Boskey
Journal:  Calcif Tissue Int       Date:  2014-08-26       Impact factor: 4.333

Review 2.  Vibrational spectroscopic techniques to assess bone quality.

Authors:  E P Paschalis; S Gamsjaeger; K Klaushofer
Journal:  Osteoporos Int       Date:  2017-04-05       Impact factor: 4.507

Review 3.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

4.  Insights into the bisphosphonate holiday: a preliminary FTIRI study.

Authors:  A L Boskey; L Spevak; Y Ma; H Wang; D C Bauer; D M Black; A V Schwartz
Journal:  Osteoporos Int       Date:  2017-12-05       Impact factor: 4.507

5.  Measures of Bone Mineral Carbonate Content and Mineral Maturity/Crystallinity for FT-IR and Raman Spectroscopic Imaging Differentially Relate to Physical-Chemical Properties of Carbonate-Substituted Hydroxyapatite.

Authors:  Erik A Taylor; Cassidy J Mileti; Sandhya Ganesan; Joo Ho Kim; Eve Donnelly
Journal:  Calcif Tissue Int       Date:  2021-03-12       Impact factor: 4.333

6.  Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.

Authors:  Marco Masci; Min Wang; Laurianne Imbert; Aileen M Barnes; Lyudmila Spevak; Lyudmila Lukashova; Yihe Huang; Yan Ma; Joan C Marini; Christina M Jacobsen; Matthew L Warman; Adele L Boskey
Journal:  Bone       Date:  2016-04-13       Impact factor: 4.398

7.  Osteocalcin affects bone mineral and mechanical properties in female mice.

Authors:  O Berezovska; G Yildirim; W C Budell; S Yagerman; B Pidhaynyy; C Bastien; M C H van der Meulen; T L Dowd
Journal:  Bone       Date:  2019-08-08       Impact factor: 4.398

8.  HBM Mice Have Altered Bone Matrix Composition and Improved Material Toughness.

Authors:  Ryan D Ross; Maleeha Mashiatulla; Alvin S Acerbo; Jonathan D Almer; Lisa M Miller; Mark L Johnson; D Rick Sumner
Journal:  Calcif Tissue Int       Date:  2016-05-26       Impact factor: 4.333

9.  The kidney sodium-phosphate co-transporter alters bone quality in an age and gender specific manner.

Authors:  Adele L Boskey; Lyudmilla Lukashova; Lyudmila Spevak; Yan Ma; Saeed R Khan
Journal:  Bone       Date:  2013-01-17       Impact factor: 4.398

10.  Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.

Authors:  B Hofstetter; S Gamsjaeger; F Varga; H Dobnig; J J Stepan; H Petto; I Pavo; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.